ASA | B | 95% CI | |
---|---|---|---|
3 months after surgery | |||
Intercept | 0.12 | 0.43 - -0.18 | |
Before RRS implementation vs after | - 0.02 | - 0.05 - 0.02 | |
Gender, male vs female | 0.02 | - 0.02 - 0.05 | |
Age | ≤ 0.01 | 0.30 - ≤0.01 | |
LOS planned ICU | ≤ 0.01 | ≤ - 0.01- ≤0.01 | |
ASA 1 tot 4 vs ASA 5 | 1 | 0.42 | 0.14 - 0.71 |
2 | 0.41 | 0.12 - 0.69 | |
3 | 0.34 | 0.05 - 0.62 | |
4 | 0.37 | 0.06 - 0.68 | |
EQ-5D pre surgery | 0.26 | 0.21- 0.31 | |
6 months after surgery | |||
Intercept | 0.25 | - 0.04 - 0.54 | |
before RRS implementation vs after | - 0.01 | - 0.05 - 0.02 | |
Gender, male vs female | 0.03 | ≤ - 0.01 - 0.06 | |
Age | ≤ 0.01 | ≤ - 0.01 - ≤0.01 | |
LOS planned ICU | ≤ 0.01 | ≤ - 0.01 - ≤0.01 | |
ASA 1 to 4 vs ASA 5 | 1 | 0.32 | 0.05 - 0.60 |
2 | 0.28 | 0.01 - 0.56 | |
3 | 0.25 | - 0.02 - 0.52 | |
4 | 0.26 | - 0.05 - 0.56 | |
EQ-5D pre-surgery | 0.24 | 0.19 - 0.29 |